Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

The conclusion is that exogen is a unique hair cycle phase and the new sampling method specifically targets this stage, which may help in future hair loss research.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Stress and alcohol affect brain chemicals differently in rats, mice, and humans, influenced by genetic differences.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Bald men may have higher heart disease risk.

Using hyaluronic acid fillers and laser together is generally safe and effective for facial rejuvenation, but careful planning is needed.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

The document concludes that recognizing oral lesions is important for diagnosing syphilis.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Obesity and lifestyle strongly affect heart aging.

Blocking certain fat production can reverse skin inflammation and hair loss.

Exposure to Corexit dispersants during the oil spill cleanup was linked to increased respiratory and eye irritation symptoms in workers.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Reduced sexual drive may be linked to male breast cancer, while anti-estrogenic factors might lower the risk.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.